| Anemia (24) |  |
| Hemophilia (11) | |
| Lymphoma (20) | |
| Anemia (24) | |
| Hemophilia (11) | |
| Lymphoma (20) | |
including leukemia, lymphoma, and bladder, breast, lung, and ovarian tumors. Staggering these drugs proved particularly powerful against a type of breast cancer cell known as triple-negative,
It reduced non-Hodgkin's lymphoma tumours to about a quarter of their size, got rid of protstate cancer entirely in two of six mice
This work was supported by a National institutes of health grant, the Samuel Waxman Cancer Research Foundation, the Leukemia and Lymphoma Society, the Rally Foundation and the Bear Necessities Foundation e
and lymphoma teams at Texas Children Hospital. Ball said STAT3 has been a target for scientists trying to shut down cancer cells.
which recently changed its name from Leukaemia & Lymphoma Research a
#chillesheelof Sickle cell Disease? Researchers from Dana-Farber/Boston Children Cancer and Blood disorders Center have found that changes to a small stretch of DNA may circumvent the genetic defect behind sickle cell disease.
its oral investigational anaplastic lymphoma kinase (ALK) inhibitor, shrank tumors (overall response rate; ORR: 50.0 percent and 47.8 percent, respectively) in people with advanced ALK-positive non-small cell lung cancer (NSCLC) whose disease had progressed following treatment with crizotinib.
The four human patients all had lymphomas, which are cancers of the lymph system, and had enlarged lymph nodes.
"Once developed fully, SNAS will lay the foundation for developing an entire new pipeline of drugs to treat a range of diseases, from psoriasis, lupus and rheumatoid arthritis to lymphoma, bladder cancer and prostate cancer."
targeting lymphoma and a form of autoimmune hepatitis.""The spherical nucleic acids always win from potency and speed standpoints,
In a study of mice, the researchers tested SNAS against lymphoma. For the animals treated with SNAS,
and destroy lymphoma cells. Next, focusing on nonalcoholic steatohepatitis (NASH), the researchers found eightfold increases in potency when animals were treated with SNAS and a 30 percent greater reduction in the animals'fibrosis score.
This gives you a catalytic effect that grows into a systemic search for cells that look for example, like lymphoma cells."
which has been linked to the development of lymphoma, leukaemia, and brain tumours, plus a number of congenital diseases that affect a person growth."
researchers are looking at the potential of such drugs as a treatment for several types of lymphoma."
whose lymphoma diagnosis was confirmed by conventional pathology from another four with benign lymph node enlargement. Along with protein analyses, the system was enhanced to successfully detect DNA--in this instance from human papilloma virus--with great sensitivity.
"The Penn team, in collaboration with Alain Rook, MD, director of the Cutaneous T-cell Lymphoma Program and a professor of Dermatology, aims to develop a molecular taxonomy for mutations in SS patients.
The approach has been used to treat leukemia as well as lymphoma, according to Dr. Rapoport, who is the Director of the Blood and Marrow Transplant Program at the University of Maryland Marlene and Stewart Greenebaum Cancer Center.
"Several drugs are quite effective in treating different types of breast cancers, lung cancer, lymphoma and other cancers at their original sites,
and lymphoma patients with a first generation of experimental T cell therapies developed by its academic partners.
In an earlier CAR-T trial at Sloan Kettering, to treat non-Hodgkin lymphoma, two patients suffered a cytokine storm
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011